Literature DB >> 30921691

Nuclear magnetic resonance spectroscopic study of the inclusion complex of (R)-tedizolid with HDAS-β-CD, β-CD, and γ-cyclodextrin in aqueous solution.

Elżbieta Bednarek1, Wojciech Bocian2, Katarzyna Michalska3.   

Abstract

NMR spectroscopy is used to investigate the host-guest complexation of (R)-tedizolid, such as tedizolid with the hydroxymethyl substituent at the C5 position of the oxazolidinone ring ((R)-TED) or tedizolid with 5-methyl dihydrogen phosphate ((R)-TED-PO4) with heptakis-(2,3-diacetyl-6-sulfo)-β-cyclodextrin (HDAS-β-CD), β-CD and γ-CD, in particular to obtain information about the mode and strength of the guest complexation into the hydrophobic cavity of the host. The complex stoichiometries of 1:1 (host:guest) and 1:2 were detected in millimolar concentrations for HDAS-β-CD and γ-CD with TED-PO4 complexes, respectively. In the meantime, the mixed of complexes with stoichiometries of 1:1 and 2:1 were found for β-CD with both TED and TED-PO4, however the 1:1 complex had a significant advantage.The binding mode was proposed. The estimated binding constants Ka of the complexes of TED or TED-PO4 with CDs differ significantly in the order HDAS-β-CD<<β-CD<<γ-CD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complexation; Cyclodextrin; NMR; Tedizolid; Tedizolid phosphate

Mesh:

Substances:

Year:  2019        PMID: 30921691     DOI: 10.1016/j.jpba.2019.02.031

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

Review 1.  Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.

Authors:  Dariusz Boczar; Katarzyna Michalska
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

2.  Explanation of the Formation of Complexes between Representatives of Oxazolidinones and HDAS-β-CD Using Molecular Modeling as a Complementary Technique to cEKC and NMR.

Authors:  Wojciech Bocian; Elżbieta Bednarek; Katarzyna Michalska
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.